SCOPUS 정보 검색 플랫폼

Journal of the American Academy of Dermatology

Volumn 69, Issue 4, 2013, Pages

Clinical remission of Merkel cell carcinoma after treatment with imatinib

(7) Loader, Dagmara Ewa a Feldmann, Robert a Baumgartner, Magdalena a Breier, Friedrich a Schrama, David b Becker, Jürgen Christian b Steiner, Andreas a

a Hietzing Hospital Vienna (Austria)

b MEDICAL UNIVERSITY OF GRAZ (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOGRANIN A; CYTOKERATIN 20; IMATINIB; SYNAPTOPHYSIN;

ABSENCE OF SIDE EFFECTS; AGED; CANCER REGRESSION; CASE REPORT; CERVICAL LYMPH NODE; CERVICAL LYMPHADENOPATHY; FEMALE; FOLLOW UP; HUMAN; LETTER; MASSETER MUSCLE; MERKEL CELL TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SUBCUTANEOUS NODULE; THORAX RADIOGRAPHY;

EID: 84884326950 PISSN: 01909622 EISSN: 10976787 Source Type: Journal
DOI: 10.1016/j.jaad.2013.03.042 Document Type: Article

Times cited : (23)

References (5)

1
- 78049433610
- A phase II trial of imatinib mesylate in Merkel cell carcinoma (neuroendocrine carcinoma of the skin): A Southwest Oncology Group study (S0331)
- W.E. Samlowski, J. Moon, R.J. Tuthill, M.C. Heinrich, N.S. Balzer-Haas, and S.A. Merl A phase II trial of imatinib mesylate in Merkel cell carcinoma (neuroendocrine carcinoma of the skin): a Southwest Oncology Group study (S0331) Am J Clin Oncol 33 2010 495 499
- (2010) Am J Clin Oncol , vol.33 , pp. 495-499
- Samlowski, W.E.¹ Moon, J.² Tuthill, R.J.³ Heinrich, M.C.⁴ Balzer-Haas, N.S.⁵ Merl, S.A.⁶

2
- 0038731316
- Juxtamebrane mutant V560GKIT is more sensitive to Imatinib (STI571) compared with wild-type c-kit whereas the kinase domain mutant D816VKit is resistant
- M.J. Frost, P.T. Ferrao, T.P. Hughes, and L.K. Ashman Juxtamebrane mutant V560GKIT is more sensitive to Imatinib (STI571) compared with wild-type c-kit whereas the kinase domain mutant D816VKit is resistant Mol Cancer Ther 1 2002 1115 1124
- (2002) Mol Cancer Ther , vol.1 , pp. 1115-1124
- Frost, M.J.¹ Ferrao, P.T.² Hughes, T.P.³ Ashman, L.K.⁴

3
- 79956083927
- Identification of the M541L sequence variation of the transmembrane KIT domain in Merkel cell carcinoma
- K. Krasagakis, M. Metaxari, M. Zervou, E.N. Stathopoulos, J. Eberle, and J. Kanitakis Identification of the M541L sequence variation of the transmembrane KIT domain in Merkel cell carcinoma Anticancer Res 31 2011 807 811
- (2011) Anticancer Res , vol.31 , pp. 807-811
- Krasagakis, K.¹ Metaxari, M.² Zervou, M.³ Stathopoulos, E.N.⁴ Eberle, J.⁵ Kanitakis, J.⁶

4
- 82455188578
- Tyrosine kinase inhibitors [in French]
- J. Robert Tyrosine kinase inhibitors [in French] Bull Cancer 98 2011 1321 1334
- (2011) Bull Cancer , vol.98 , pp. 1321-1334
- Robert, J.¹

5
- 70349331507
- Response to a novel multitargeted tyrosine kinase inhibitor pazopanib in metastatic Merkel cell carcinoma
- M.S. Davids, A. Charlton, S.S. Ng, M.L. Chong, K. Laubscher, M. Dar, and J. Hodge Response to a novel multitargeted tyrosine kinase inhibitor pazopanib in metastatic Merkel cell carcinoma J Clin Oncol 27 2009 e97 100
- (2009) J Clin Oncol , vol.27 , pp. 97-100
- Davids, M.S.¹ Charlton, A.² Ng, S.S.³ Chong, M.L.⁴ Laubscher, K.⁵ Dar, M.⁶ Hodge, J.⁷

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.